Compare LENZ & SAGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LENZ | SAGU |
|---|---|---|
| Founded | 2019 | 2025 |
| Country | United States | Mauritius |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 161.1M |
| IPO Year | 2021 | 2025 |
| Metric | LENZ | SAGU |
|---|---|---|
| Price | $3.79 | $10.01 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.00 | N/A |
| AVG Volume (30 Days) | ★ 666.8K | 27.9K |
| Earning Date | 11-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $153.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.60 | $9.88 |
| 52 Week High | $49.85 | $10.05 |
| Indicator | LENZ | SAGU |
|---|---|---|
| Relative Strength Index (RSI) | 33.95 | 53.23 |
| Support Level | $3.60 | $9.95 |
| Resistance Level | $6.11 | $10.05 |
| Average True Range (ATR) | 0.20 | 0.02 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 23.38 | 63.64 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Shreya Acquisition Group is a blank check company.